Lymphoma Clinical Trials in Wenzhou
5 recruitingWenzhou, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
AstraZeneca1,018 enrolled135 locationsNCT06549595
Recruiting
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Hoffmann-La Roche300 enrolled12 locationsNCT07200375
Recruiting
Phase 3
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Lymphoma
Hoffmann-La Roche182 enrolled75 locationsNCT06084936
Recruiting
Phase 3
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Non-Hodgkin's LymphomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled17 locationsNCT06520163
Recruiting
Phase 2
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL)
Second Affiliated Hospital, School of Medicine, Zhejiang University51 enrolled18 locationsNCT07022223